Depomed, Inc. (DEPO) Thursday said it acquired all rights to Zipsor liquid filled capsules from Xanodyne Pharmaceuticals, Inc., in return for $25.9 million of cash and potential milestone payments based on sales of Zipsor and assumption of certain liabilities.
Zipsor is a non-steroidal anti-inflammatory drug, known to relieve mild to moderate acute pain in adults.
For comments and feedback: editorial@rttnews.com